JOHN R CORBOY

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology AURORA, CO NPI 1922045228

General Payments — all program years on this page

$7,337.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $873.46 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $873.4610

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Carl Zeiss Meditec USA, Inc. $303.801
NOVARTIS PHARMACEUTICALS CORPORATION $294.593
GENZYME CORPORATION $146.251
Celgene Corporation $101.434
Amgen Inc. $27.391

By program year

Program yearAmountRecords
2018 $67.852
2019 $30.092
2021 $3,362.385
2022 $2,683.103
2023 $320.4414
2024 $873.4610

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086618281 Novartis Pharmaceuticals Corporation $21.80 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086618325 Novartis Pharmaceuticals Corporation $136.38 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086618327 Novartis Pharmaceuticals Corporation $136.41 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101086977 Celgene Corporation $29.25 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101086979 Celgene Corporation $25.38 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101086981 Celgene Corporation $24.36 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101086985 Celgene Corporation $22.44 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111554162 Amgen Inc. $27.39 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010270 GENZYME CORPORATION $146.25 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153259946 Carl Zeiss Meditec USA, Inc. $303.80 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.